Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formeta plus carboplatin in non-squamous non-small cell lung cancer
IRCT2016091322610N2Phase 2Completed
- Sponsor
- Cobel Darou
- Start
- Sep 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of carboplatin in non-small cell lung cancer (NSCLC), sponsored by Cobel Darou. Started Sep 2016; status: completed.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on IRCT2016091322610N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016091322610N2.